# FNDC5/Irisin-dependent renoprotection of resistance training in myocardial infarction–induced Type 2 cardiorenal syndrome

**Authors:** Weiyu Fu, Jun Lin, Wenqian Lin, Kai Zeng

PMC · DOI: 10.1371/journal.pone.0342468 · PLOS One · 2026-02-20

## TL;DR

Resistance training helps protect the kidneys in a type of heart-kidney disease, and this benefit is partly due to a protein called Irisin.

## Contribution

This study shows that resistance training protects the kidneys in heart-induced kidney disease via the FNDC5/Irisin pathway.

## Key findings

- Resistance training reduced kidney damage and oxidative stress in mice with heart disease.
- The protective effects were reduced in mice lacking the FNDC5 gene.
- Irisin and AICAR reduced oxidative stress and fibrosis in kidney cells in the lab.

## Abstract

Type 2 cardiorenal syndrome (CRS), driven by chronic myocardial infarction (MI), is characterized by renal fibrosis and oxidative stress, yet underlying mechanisms and therapies are poorly defined. This study investigated whether resistance training protects against MI-induced renal injury via the FNDC5/Irisin axis. Male wild-type (WT) and global Fndc5 knockout (KO) mice were subjected to MI or sham surgery and then allocated to sedentary or ladder-climbing resistance training groups for 4 weeks (n = 8 per group). An in vitro model was established using H2O2-stimulated human renal tubular (HKC) cells. We found that resistance training upregulated renal FNDC5 expression, lowered serum creatinine and blood urea nitrogen levels, and attenuated tubular injury in WT mice with CRS, but these benefits were markedly blunted in KO mice. Training reduced renal malondialdehyde content, enhanced superoxide dismutase 1/2 expression, and decreased collagen deposition alongside downregulation of fibrotic markers (Collagen-I/III, α-SMA). These improvements were associated with suppressed activation of the renal TGF-β1/Smad2/3 pathway in WT but not in KO mice. In HKC cells, recombinant Irisin and the AMPK agonist AICAR mitigated H2O2-induced oxidative stress, fibrotic protein expression, and Smad2/3 phosphorylation. We conclude that resistance exercise ameliorates renal oxidative stress and fibrosis in Type 2 CRS, effects that are substantially mediated by, but not exclusively dependent on, the FNDC5/Irisin axis. Our work highlights FNDC5/Irisin as a key amplifier of exercise-induced renoprotection and supports the therapeutic potential of resistance training in cardiorenal syndrome.

## Linked entities

- **Genes:** FNDC5 (fibronectin type III domain containing 5) [NCBI Gene 252995], ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], SMAD2 (SMAD family member 2) [NCBI Gene 4087], SMAD3 (SMAD family member 3) [NCBI Gene 4088], PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562]
- **Proteins:** FNDC5 (fibronectin type III domain containing 5), MSD1 (manganese superoxide dismutase 1), CSD2 (copper/zinc superoxide dismutase 2), ACTA1 (actin alpha 1, skeletal muscle), TGFB1 (transforming growth factor beta 1), Smad2/3 (Smad2/3 transcription factor)
- **Chemicals:** H2O2 (PubChem CID 784), AICAR (PubChem CID 65110)
- **Diseases:** myocardial infarction (MONDO:0005068)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Cdh2 (cadherin 2) [NCBI Gene 12558] {aka CDHN, N-CAD, Ncad}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 81687], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Scr (scruffy) [NCBI Gene 109559], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, FNDC5 (fibronectin type III domain containing 5) [NCBI Gene 252995] {aka FRCP2, irisin}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 81686], Vim (vimentin) [NCBI Gene 22352], Nr3c2 (nuclear receptor subfamily 3, group C, member 2) [NCBI Gene 110784] {aka MR, Mlr}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Sod1 (superoxide dismutase 1, soluble) [NCBI Gene 20655] {aka B430204E11Rik, Cu/Zn-SOD, CuZnSOD, Ipo-1, Ipo1, SODC}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, ATIC (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase) [NCBI Gene 471] {aka AICAR, AICARFT, HEL-S-70p, IMPCHASE, PURH}, Ccn2 (cellular communication network factor 2) [NCBI Gene 64032] {aka CTGRP, Ctgf}, Smad4 (SMAD family member 4) [NCBI Gene 17128] {aka D18Wsu70e, DPC4, Madh4}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, Ccn2 (cellular communication network factor 2) [NCBI Gene 14219] {aka Ctgf, Fisp12, Hcs24, fisp-12}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Tgfbr2 (transforming growth factor, beta receptor II) [NCBI Gene 21813] {aka 1110020H15Rik, DNIIR, RIIDN, TBR-II, TbetaR-II, TbetaRII}, Fndc5 (fibronectin type III domain containing 5) [NCBI Gene 384061] {aka 1500001L03Rik, PeP, Pxp}, Sod2 (superoxide dismutase 2, mitochondrial) [NCBI Gene 20656] {aka MnSOD, Sod-2}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, Fndc5 (fibronectin type III domain containing 5) [NCBI Gene 260327]
- **Diseases:** renal insufficiency or dysfunction (MESH:D012078), cardiovascular or renal diseases (MESH:D002318), MI (MESH:D009203), ischemic hearts (MESH:D017202), renal involvement (MESH:C565423), 2 CRS (MESH:D059347), Renal tubular injury (MESH:D015499), hypertension (MESH:D006973), overdose (MESH:D062787), chronic (MESH:D002908), collagen (MESH:D003095), kidney injury (MESH:D007674), HF (MESH:D006333), cardiac dysfunction (MESH:D006331), dyspneic breathing (MESH:D004417), tubular damage (MESH:D000230), postoperative pain (MESH:D010149), CKD (MESH:D051436), inflammation (MESH:D007249), injury (MESH:D014947), Fibrosis (MESH:D005355), loss (MESH:D016388), ischemia (MESH:D007511), vacuolar degeneration (MESH:C536522), damage (MESH:D020263), MR (MESH:D008944), Hypoxia (MESH:D000860), LVIDd (MESH:D018487), remote organ injury (MESH:D009102), ventricular arrhythmias (MESH:D001145), acute kidney injury (MESH:D058186)
- **Chemicals:** AICAR (MESH:C031143), MDA (MESH:D008315), Masson's (-), H2O2 (MESH:D006861), PVDF (MESH:C024865), creatinine (MESH:D003404), bupivacaine (MESH:D002045), CO2 (MESH:D002245), F12 (MESH:C007782), Paraffin (MESH:D010232), saline (MESH:D012965), oxygen (MESH:D010100), SDS (MESH:D012967), water (MESH:D014867), isoflurane (MESH:D007530), Trizol (MESH:C411644)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), embryonic — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_M624), HKC — Homo sapiens (Human), Transformed cell line (CVCL_WZ51)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12923059/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923059/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12923059/full.md

---
Source: https://tomesphere.com/paper/PMC12923059